Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 2214 entries
Sorted by: Best Match Show Resources per page
[Guidance and management of students during the practice period].

[Kango] Japanese journal of nursing

Kiyama K.
PMID: 5210488
Kango. 1971 Sep;23(9):132-6.

No abstract available.

Cite
Kiyama K. [Guidance and management of students during the practice period]. Kango. 1971;23(9):132-6
Kiyama, K. (1971). [Guidance and management of students during the practice period]. [Kango] Japanese journal of nursing, 23(9), 132-6.
Kiyama, K. "[Guidance and management of students during the practice period]." [Kango] Japanese journal of nursing vol. 23,9 (1971): 132-6.
Kiyama K. [Guidance and management of students during the practice period]. Kango. 1971 Sep;23(9):132-6. Japanese. PMID: 5210488.
Copy Download .nbib Format: NLM
Intraductal Ultrasonography as a Local Assessment Before Magnetic Compression Anastomosis for Obstructed Choledochojejunostomy.

Gastroenterology research

Kawabata H, Hitomi M, Inoue N, Kawakatsu Y, Okazaki Y, Miyata M.
PMID: 28912914
Gastroenterology Res. 2017 Aug;10(4):255-258. doi: 10.14740/gr842w. Epub 2017 Aug 31.

Magnetic compression anastomosis (MCA) has been developed as a non-surgical alternative treatment for biliary obstruction without serious complications. A 70-year-old woman who had undergone pancreaticoduodenectomy with modified Child reconstruction for pancreatic head cancer suffered from obstructed choledochojejunostomy with no...

Cite
Kawabata H, Hitomi M, Inoue N, et al. Intraductal Ultrasonography as a Local Assessment Before Magnetic Compression Anastomosis for Obstructed Choledochojejunostomy. Gastroenterology Res. 2017;10(4):255-258doi: 10.14740/gr842w.
Kawabata, H., Hitomi, M., Inoue, N., Kawakatsu, Y., Okazaki, Y., & Miyata, M. (2017). Intraductal Ultrasonography as a Local Assessment Before Magnetic Compression Anastomosis for Obstructed Choledochojejunostomy. Gastroenterology research, 10(4), 255-258. https://doi.org/10.14740/gr842w
Kawabata, Hideaki, et al. "Intraductal Ultrasonography as a Local Assessment Before Magnetic Compression Anastomosis for Obstructed Choledochojejunostomy." Gastroenterology research vol. 10,4 (2017): 255-258. doi: https://doi.org/10.14740/gr842w
Kawabata H, Hitomi M, Inoue N, Kawakatsu Y, Okazaki Y, Miyata M. Intraductal Ultrasonography as a Local Assessment Before Magnetic Compression Anastomosis for Obstructed Choledochojejunostomy. Gastroenterology Res. 2017 Aug;10(4):255-258. doi: 10.14740/gr842w. Epub 2017 Aug 31. PMID: 28912914; PMCID: PMC5593447.
Copy Download .nbib Format: NLM
Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma.

Acta pharmaceutica Sinica. B

Sato N, Cheng XB, Kohi S, Koga A, Hirata K.
PMID: 27006892
Acta Pharm Sin B. 2016 Mar;6(2):101-5. doi: 10.1016/j.apsb.2016.01.002. Epub 2016 Jan 21.

Progression of cancer is often associated with interactions between cancer cells and extracellular matrix (ECM) surrounding them. Increasing evidence has suggested that accumulation of hyaluronan (HA), a major component of ECM, provides a favorable microenvironment for cancer progression. Pancreatic...

Cite
Sato N, Cheng XB, Kohi S, et al. Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma. Acta Pharm Sin B. 2016;6(2):101-5doi: 10.1016/j.apsb.2016.01.002.
Sato, N., Cheng, X. B., Kohi, S., Koga, A., & Hirata, K. (2016). Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma. Acta pharmaceutica Sinica. B, 6(2), 101-5. https://doi.org/10.1016/j.apsb.2016.01.002
Sato, Norihiro, et al. "Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma." Acta pharmaceutica Sinica. B vol. 6,2 (2016): 101-5. doi: https://doi.org/10.1016/j.apsb.2016.01.002
Sato N, Cheng XB, Kohi S, Koga A, Hirata K. Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma. Acta Pharm Sin B. 2016 Mar;6(2):101-5. doi: 10.1016/j.apsb.2016.01.002. Epub 2016 Jan 21. PMID: 27006892; PMCID: PMC4788704.
Copy Download .nbib Format: NLM
Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report.

Oncology letters

Kawasaki K, Hamamoto Y, Suzuki T, Hirata K, Sukawa Y, Kasuga A, Hayashi Y, Takaishi H, Kameyama K, Kanai T.
PMID: 28927133
Oncol Lett. 2017 Sep;14(3):3697-3700. doi: 10.3892/ol.2017.6601. Epub 2017 Jul 18.

Rebiopsy is considered an option for specific types of cancer, such as breast, non-small cell lung, and prostate cancer, in clinical trials and in practice. The benefit of rebiopsy comes from the selection of a new treatment strategy based...

Cite
Kawasaki K, Hamamoto Y, Suzuki T, et al. Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report. Oncol Lett. 2017;14(3):3697-3700doi: 10.3892/ol.2017.6601.
Kawasaki, K., Hamamoto, Y., Suzuki, T., Hirata, K., Sukawa, Y., Kasuga, A., Hayashi, Y., Takaishi, H., Kameyama, K., & Kanai, T. (2017). Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report. Oncology letters, 14(3), 3697-3700. https://doi.org/10.3892/ol.2017.6601
Kawasaki, Kenta, et al. "Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report." Oncology letters vol. 14,3 (2017): 3697-3700. doi: https://doi.org/10.3892/ol.2017.6601
Kawasaki K, Hamamoto Y, Suzuki T, Hirata K, Sukawa Y, Kasuga A, Hayashi Y, Takaishi H, Kameyama K, Kanai T. Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report. Oncol Lett. 2017 Sep;14(3):3697-3700. doi: 10.3892/ol.2017.6601. Epub 2017 Jul 18. PMID: 28927133; PMCID: PMC5587936.
Copy Download .nbib Format: NLM
Screening in crystalline liquids protects energetic carriers in hybrid perovskites.

Science (New York, N.Y.)

Zhu H, Miyata K, Fu Y, Wang J, Joshi PP, Niesner D, Williams KW, Jin S, Zhu XY.
PMID: 27708033
Science. 2016 Sep 23;353(6306):1409-1413. doi: 10.1126/science.aaf9570.

Hybrid lead halide perovskites exhibit carrier properties that resemble those of pristine nonpolar semiconductors despite static and dynamic disorder, but how carriers are protected from efficient scattering with charged defects and optical phonons is unknown. Here, we reveal the...

Cite
Zhu H, Miyata K, Fu Y, et al. Screening in crystalline liquids protects energetic carriers in hybrid perovskites. Science. 2016;353(6306):1409-1413doi: 10.1126/science.aaf9570.
Zhu, H., Miyata, K., Fu, Y., Wang, J., Joshi, P. P., Niesner, D., Williams, K. W., Jin, S., & Zhu, X. Y. (2016). Screening in crystalline liquids protects energetic carriers in hybrid perovskites. Science (New York, N.Y.), 353(6306), 1409-1413. https://doi.org/10.1126/science.aaf9570
Zhu, Haiming, et al. "Screening in crystalline liquids protects energetic carriers in hybrid perovskites." Science (New York, N.Y.) vol. 353,6306 (2016): 1409-1413. doi: https://doi.org/10.1126/science.aaf9570
Zhu H, Miyata K, Fu Y, Wang J, Joshi PP, Niesner D, Williams KW, Jin S, Zhu XY. Screening in crystalline liquids protects energetic carriers in hybrid perovskites. Science. 2016 Sep 23;353(6306):1409-1413. doi: 10.1126/science.aaf9570. PMID: 27708033.
Copy Download .nbib Format: NLM
Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer.

Oncology letters

Miyata Y, Mitsunari K, Akihiro A, Watanabe SI, Matsuo T, Ohba K, Sakai H.
PMID: 28356963
Oncol Lett. 2017 Feb;13(2):811-818. doi: 10.3892/ol.2016.5484. Epub 2016 Dec 12.

In patients with advanced urothelial cancer (UC), a combination of cisplatin (CDDP) and gemcitabine (GEM) is the most commonly used first-line systematic chemotherapy regimen. Although no standard regime for the treatment of CDDP-resistant UC has been established, GEM-based regimens...

Cite
Miyata Y, Mitsunari K, Akihiro A, et al. Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer. Oncol Lett. 2016;13(2):811-818doi: 10.3892/ol.2016.5484.
Miyata, Y., Mitsunari, K., Akihiro, A., Watanabe, S. I., Matsuo, T., Ohba, K., & Sakai, H. (2017). Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer. Oncology letters, 13(2), 811-818. https://doi.org/10.3892/ol.2016.5484
Miyata, Yasuyoshi, et al. "Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer." Oncology letters vol. 13,2 (2017): 811-818. doi: https://doi.org/10.3892/ol.2016.5484
Miyata Y, Mitsunari K, Akihiro A, Watanabe SI, Matsuo T, Ohba K, Sakai H. Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer. Oncol Lett. 2017 Feb;13(2):811-818. doi: 10.3892/ol.2016.5484. Epub 2016 Dec 12. PMID: 28356963; PMCID: PMC5351343.
Copy Download .nbib Format: NLM
Whole Genome Sequence of the Non-Microcystin-Producing Microcystis aeruginosa Strain NIES-44.

Genome announcements

Okano K, Miyata N, Ozaki Y.
PMID: 25792056
Genome Announc. 2015 Mar 19;3(2). doi: 10.1128/genomeA.00135-15.

Microcystis aeruginosa is a typical algal bloom-forming cyanobacterium. This report describes the whole-genome sequence of a non-microcystin-producing strain of Microcystis aeruginosa, NIES-44, which was isolated from a Japanese lake.

Cite
Okano K, Miyata N, Ozaki Y. Whole Genome Sequence of the Non-Microcystin-Producing Microcystis aeruginosa Strain NIES-44. Genome Announc. 2015;3(2)doi: 10.1128/genomeA.00135-15.
Okano, K., Miyata, N., & Ozaki, Y. (2015). Whole Genome Sequence of the Non-Microcystin-Producing Microcystis aeruginosa Strain NIES-44. Genome announcements, 3(2), . https://doi.org/10.1128/genomeA.00135-15
Okano, Kunihiro, et al. "Whole Genome Sequence of the Non-Microcystin-Producing Microcystis aeruginosa Strain NIES-44." Genome announcements vol. 3,2 (2015). doi: https://doi.org/10.1128/genomeA.00135-15
Okano K, Miyata N, Ozaki Y. Whole Genome Sequence of the Non-Microcystin-Producing Microcystis aeruginosa Strain NIES-44. Genome Announc. 2015 Mar 19;3(2). doi: 10.1128/genomeA.00135-15. PMID: 25792056; PMCID: PMC4384123.
Copy Download .nbib Format: NLM
Purification of Pomacea canaliculata α-Fucosidase Isoforms with Different Thermostabilities.

Bioscience, biotechnology, and biochemistry

Hirata K, Aso Y, Yasuda S, Ishiguro M.
PMID: 27392563
Biosci Biotechnol Biochem. 1998;62(4):807-10. doi: 10.1271/bbb.62.807.

Two isoforms, F1 (pI 4.7) and F2 (pI 4.9), of α-fucosidase were purified from the viscera of Pomacea canaliculata. The thermostability of F1 was higher than that of F2. Both were 260-kDa proteins containing polypeptides (55 and 52 kDa)...

Cite
Hirata K, Aso Y, Yasuda S, et al. Purification of Pomacea canaliculata α-Fucosidase Isoforms with Different Thermostabilities. Biosci Biotechnol Biochem. 1998;62(4):807-10doi: 10.1271/bbb.62.807.
Hirata, K., Aso, Y., Yasuda, S., & Ishiguro, M. (1998). Purification of Pomacea canaliculata α-Fucosidase Isoforms with Different Thermostabilities. Bioscience, biotechnology, and biochemistry, 62(4), 807-10. https://doi.org/10.1271/bbb.62.807
Hirata, K, et al. "Purification of Pomacea canaliculata α-Fucosidase Isoforms with Different Thermostabilities." Bioscience, biotechnology, and biochemistry vol. 62,4 (1998): 807-10. doi: https://doi.org/10.1271/bbb.62.807
Hirata K, Aso Y, Yasuda S, Ishiguro M. Purification of Pomacea canaliculata α-Fucosidase Isoforms with Different Thermostabilities. Biosci Biotechnol Biochem. 1998;62(4):807-10. doi: 10.1271/bbb.62.807. PMID: 27392563.
Copy Download .nbib Format: NLM
Vascularity of Intrahepatic Cholangiocarcinoma on Computed Tomography is Predictive of Lymph Node Metastasis.

Annals of surgical oncology

Yamamoto Y, Türkoğlu MA, Aramaki T, Sugiura T, Okamura Y, Ito T, Ashida R, Uemura S, Miyata T, Kato Y, Kakuta Y, Nakanuma Y, Uesaka K.
PMID: 27393571
Ann Surg Oncol. 2016 Aug;23:485-493. doi: 10.1245/s10434-016-5382-1. Epub 2016 Jul 08.

BACKGROUND: The indications for lymph node dissection (LND) for intrahepatic cholangiocarcinoma (ICC) are controversial.METHODS: Seventy patients with mass-forming dominant ICC underwent hepatectomy with systematic LND or lymph node sampling between 2003 and 2013. We defined the computed tomography (CT)...

Cite
Yamamoto Y, Türkoğlu MA, Aramaki T, et al. Vascularity of Intrahepatic Cholangiocarcinoma on Computed Tomography is Predictive of Lymph Node Metastasis. Ann Surg Oncol. 2016;23:485-493doi: 10.1245/s10434-016-5382-1.
Yamamoto, Y., Türkoğlu, M. A., Aramaki, T., Sugiura, T., Okamura, Y., Ito, T., Ashida, R., Uemura, S., Miyata, T., Kato, Y., Kakuta, Y., Nakanuma, Y., & Uesaka, K. (2016). Vascularity of Intrahepatic Cholangiocarcinoma on Computed Tomography is Predictive of Lymph Node Metastasis. Annals of surgical oncology, 23485-493. https://doi.org/10.1245/s10434-016-5382-1
Yamamoto, Yusuke, et al. "Vascularity of Intrahepatic Cholangiocarcinoma on Computed Tomography is Predictive of Lymph Node Metastasis." Annals of surgical oncology vol. 23 (2016): 485-493. doi: https://doi.org/10.1245/s10434-016-5382-1
Yamamoto Y, Türkoğlu MA, Aramaki T, Sugiura T, Okamura Y, Ito T, Ashida R, Uemura S, Miyata T, Kato Y, Kakuta Y, Nakanuma Y, Uesaka K. Vascularity of Intrahepatic Cholangiocarcinoma on Computed Tomography is Predictive of Lymph Node Metastasis. Ann Surg Oncol. 2016 Aug;23:485-493. doi: 10.1245/s10434-016-5382-1. Epub 2016 Jul 08. PMID: 27393571.
Copy Download .nbib Format: NLM
Preface.

Neuropsychobiology

Kinoshita T, Hirata K.
PMID: 25766376
Neuropsychobiology. 2015;71(1):5. doi: 10.1159/000375241. Epub 2015 Feb 27.

No abstract available.

Cite
Kinoshita T, Hirata K. Preface. Neuropsychobiology. 2015;71(1):5doi: 10.1159/000375241.
Kinoshita, T., & Hirata, K. (2015). Preface. Neuropsychobiology, 71(1), 5. https://doi.org/10.1159/000375241
Kinoshita, Toshihiko, and Hirata, Koichi. "Preface." Neuropsychobiology vol. 71,1 (2015): 5. doi: https://doi.org/10.1159/000375241
Kinoshita T, Hirata K. Preface. Neuropsychobiology. 2015;71(1):5. doi: 10.1159/000375241. Epub 2015 Feb 27. PMID: 25766376.
Copy Download .nbib Format: NLM
Multiplex cytokine analysis of Werner syndrome.

Intractable & rare diseases research

Goto M, Hayata K, Chiba J, Matsuura M, Iwaki-Egawa S, Watanabe Y.
PMID: 26668779
Intractable Rare Dis Res. 2015 Nov;4(4):190-7. doi: 10.5582/irdr.2015.01035.

We reported a minor inflammation-driven ageing (inflammageing) assessed by highly sensitive CRP (hsCRP) in normal individuals and patients with Werner syndrome (WS), followed by an ageing associated Th2-biased cytokine change in normal ageing in the previous papers. To further...

Cite
Goto M, Hayata K, Chiba J, et al. Multiplex cytokine analysis of Werner syndrome. Intractable Rare Dis Res. 2015;4(4):190-7doi: 10.5582/irdr.2015.01035.
Goto, M., Hayata, K., Chiba, J., Matsuura, M., Iwaki-Egawa, S., & Watanabe, Y. (2015). Multiplex cytokine analysis of Werner syndrome. Intractable & rare diseases research, 4(4), 190-7. https://doi.org/10.5582/irdr.2015.01035
Goto, Makoto, et al. "Multiplex cytokine analysis of Werner syndrome." Intractable & rare diseases research vol. 4,4 (2015): 190-7. doi: https://doi.org/10.5582/irdr.2015.01035
Goto M, Hayata K, Chiba J, Matsuura M, Iwaki-Egawa S, Watanabe Y. Multiplex cytokine analysis of Werner syndrome. Intractable Rare Dis Res. 2015 Nov;4(4):190-7. doi: 10.5582/irdr.2015.01035. PMID: 26668779; PMCID: PMC4660860.
Copy Download .nbib Format: NLM
A case of idiopathic encapsulating peritoneal sclerosis with intractable ileus successfully treated by surgery and steroid therapy.

Clinical journal of gastroenterology

Ikeda Y, Sato Y, Kamihara Y, Hirakawa M, Onuma H, Takada K, Hayashi T, Sato T, Miyanishi K, Takimoto R, Kohune M, Nobuoka T, Noguchi H, Oi M, Honma H, Hirata K, Hasegawa T, Kato J.
PMID: 26181733
Clin J Gastroenterol. 2013 Aug;6(4):295-8. doi: 10.1007/s12328-013-0395-9. Epub 2013 Jun 20.

Encapsulating peritoneal sclerosis (EPS) occurring without a history of peritoneal dialysis is rare. We report on a patient with idiopathic EPS following intractable ileus who was successfully treated by surgery and postoperative steroid therapy without any sign of recurrence....

Cite
Ikeda Y, Sato Y, Kamihara Y, et al. A case of idiopathic encapsulating peritoneal sclerosis with intractable ileus successfully treated by surgery and steroid therapy. Clin J Gastroenterol. 2013;6(4):295-8doi: 10.1007/s12328-013-0395-9.
Ikeda, Y., Sato, Y., Kamihara, Y., Hirakawa, M., Onuma, H., Takada, K., Hayashi, T., Sato, T., Miyanishi, K., Takimoto, R., Kohune, M., Nobuoka, T., Noguchi, H., Oi, M., Honma, H., Hirata, K., Hasegawa, T., & Kato, J. (2013). A case of idiopathic encapsulating peritoneal sclerosis with intractable ileus successfully treated by surgery and steroid therapy. Clinical journal of gastroenterology, 6(4), 295-8. https://doi.org/10.1007/s12328-013-0395-9
Ikeda, Yuuki, et al. "A case of idiopathic encapsulating peritoneal sclerosis with intractable ileus successfully treated by surgery and steroid therapy." Clinical journal of gastroenterology vol. 6,4 (2013): 295-8. doi: https://doi.org/10.1007/s12328-013-0395-9
Ikeda Y, Sato Y, Kamihara Y, Hirakawa M, Onuma H, Takada K, Hayashi T, Sato T, Miyanishi K, Takimoto R, Kohune M, Nobuoka T, Noguchi H, Oi M, Honma H, Hirata K, Hasegawa T, Kato J. A case of idiopathic encapsulating peritoneal sclerosis with intractable ileus successfully treated by surgery and steroid therapy. Clin J Gastroenterol. 2013 Aug;6(4):295-8. doi: 10.1007/s12328-013-0395-9. Epub 2013 Jun 20. PMID: 26181733.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 2214 entries